Bee venom ameliorates ovalbumin induced allergic asthma via modulating CD4+CD25+ regulatory T cells in mice

Cytokine

Volumn 61, Issue 1, 2013, Pages 256-265

  Choi, Myoung Suk ^a   Park, Soojin ^a   Choi, Taewon ^a   Lee, Gihyun ^a   Haam, Kyoung Keun ^a   Hong, Moo Chang ^a   Min, Byung Il ^a   Bae, Hyunsu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Asthma; Bee venom; CD4+CD25+Foxp3+ regulatory T cell; Treg

Indexed keywords

BEE VENOM; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CD4+ CD25+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; LUNG LAVAGE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; SPLEEN CELL; T CELL DEPLETION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD4; ASTHMA; BEE VENOMS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN E; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; LUNG; MICE; OVALBUMIN; T-LYMPHOCYTES, REGULATORY;

APOIDEA; MURINAE; MUS;

EID: 84869879106     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.10.005     Document Type: Article

References (23)

1. Djukanovic R., Roche W.R., Wilson J.W., Beasley C.R., Twentyman O.P., Howarth R.H., et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990, 142:434-457.
2. Braman S.S. The global burden of asthma. Chest 2006, 130:4S-12S.
3. Elias J.A., Lee C.G., Zheng T., Ma B., Homer R.J., Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003, 111:291-297.
4. Chung K.F., Barnes P.J. Cytokines in asthma. Thorax 1999, 54:825-857.
5. Holgate S.T. Inflammatory and structural changes in the airways of patients with asthma. Respir Med 2000, 94(Suppl D):S3-S6.
6. Gleich G.J. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000, 105:651-663.
7. Seroogy C.M., Gern J.E. The role of T regulatory cells in asthma. J Allergy Clin Immunol 2005, 116:996-999.
8. + Treg development and function during allergic airway inflammation in vivo. J Clin Invest 2005, 115:313-325.
9. Chen J., Lariviere W.R. The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword. Prog Neurobiol 2010, 92:151-183.
10. Kwon Y.B., Kang M.S., Kim H.W., Ham T.W., Yim Y.K., Jeong S.H., et al. Antinociceptive effects of bee venom acupuncture (apipuncture) in rodent animal models: a comparative study of acupoint versus non-acupoint stimulation. Acupunct Electrother Res 2001, 26:59-68.
11. Kwon Y.B., Kim J.H., Yoon J.H., Lee J.D., Han H.J., Mar W.C., et al. The analgesic efficacy of bee venom acupuncture for knee osteoarthritis: a comparative study with needle acupuncture. Am J Chin Med 2001, 29:187-199.
12. Kwon Y.B., Lee J.D., Lee H.J., Han H.J., Mar W.C., Kang S.K., et al. Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain 2001, 90:271-280.
13. Nam S., Ko E., Park S.K., Ko S., Jun C.Y., Shin M.K., et al. Bee venom modulates murine Th1/Th2 lineage development. Int Immunopharmacol 2005, 5:1406-1414.
14. Lee H., Lee E.J., Kim H., Lee G., Um E.J., Kim Y., et al. Bee venom-associated Th1/Th2 immunoglobulin class switching results in immune tolerance of NZB/W F1 murine lupus nephritis. Am J Nephrol 2011, 34:163-172.
15. +CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007, 119:1258-1266.
16. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
17. Raimondi G., Turner M.S., Thomson A.W., Morel P.A. Naturally occurring regulatory T cells: recent insights in health and disease. Crit Rev Immunol 2007, 27:61-95.
18. + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004, 199:971-979.
19. Akdis C.A., Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009, 123:735-746. quiz 747-8.
20. Meiler F., Klunker S., Zimmermann M., Akdis C.A., Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 2008, 63:1455-1463.
21. Akdis C.A., Blaser K. Principles of specific immunotherapy of IgE-induced allergic reactions. Ther Umsch 2001, 58:274-277.
22. Muller U., Akdis C.A., Fricker M., Akdis M., Blesken T., Bettens F., et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998, 101:747-754.
23. Akdis C.A., Blaser K. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 1999, 13:603-609.